Trial · NCT04291508
Results by group84
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 84
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Days Alive and Free of Organ Support to Day 28 | IV Acetaminophen-Active | 20.2 | Standard Deviation 10.6 | days | |
| Days Alive and Free of Organ Support to Day 28 | IV Vitamin C-Active | 20.5 | Standard Deviation 9.5 | days | |
| Days Alive and Free of Organ Support to Day 28 | Acetaminophen-Placebo | 19.7 | Standard Deviation 10.5 | days | |
| Days Alive and Free of Organ Support to Day 28 | Vitamin C-Placebo | 18.4 | Standard Deviation 11.7 | days | |
| 28-day All Cause Mortality | IV Acetaminophen-Active | 39 | Participants | ||
| 28-day All Cause Mortality | IV Vitamin C-Active | 6 | Participants | ||
| 28-day All Cause Mortality | Acetaminophen-Placebo | 43 | Participants | ||
| 28-day All Cause Mortality | Vitamin C-Placebo | 6 | Participants | ||
| Days Free of Assisted Ventilation to Day 28 | IV Acetaminophen-Active | 21.5 | Standard Deviation 10.2 | days | |
| Days Free of Assisted Ventilation to Day 28 | IV Vitamin C-Active | 21.6 | Standard Deviation 9.4 | days | |
| Days Free of Assisted Ventilation to Day 28 | Acetaminophen-Placebo | 20.6 | Standard Deviation 10.5 | days | |
| Days Free of Assisted Ventilation to Day 28 | Vitamin C-Placebo | 19.5 | Standard Deviation 11.7 | days | |
| Days Free of Renal Replacement Therapy to Day 28 in Overall Cohort | IV Acetaminophen-Active | 23.7 | Standard Deviation 9.0 | days | |
| Days Free of Renal Replacement Therapy to Day 28 in Overall Cohort | IV Vitamin C-Active | 24.8 | Standard Deviation 7.8 | days | |
| Days Free of Renal Replacement Therapy to Day 28 in Overall Cohort | Acetaminophen-Placebo | 23.9 | Standard Deviation 8.4 | days | |
| Days Free of Renal Replacement Therapy to Day 28 in Overall Cohort | Vitamin C-Placebo | 20.8 | Standard Deviation 10.9 | days | |
| Days Free of Vasopressors to Day 28 in Overall Cohort | IV Acetaminophen-Active | 22.2 | Standard Deviation 9.4 | days | |
| Days Free of Vasopressors to Day 28 in Overall Cohort | IV Vitamin C-Active | 22.6 | Standard Deviation 8.6 | days | |
| Days Free of Vasopressors to Day 28 in Overall Cohort | Acetaminophen-Placebo | 23.9 | Standard Deviation 8.4 | days | |
| Days Free of Vasopressors to Day 28 in Overall Cohort | Vitamin C-Placebo | 19.1 | Standard Deviation 11.3 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04291508/results